NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
3.240
-0.120 (-3.57%)
At close: Aug 27, 2025, 4:00 PM
3.220
-0.020 (-0.62%)
After-hours: Aug 27, 2025, 7:59 PM EDT
NuCana Market Cap
NuCana has a market cap or net worth of $6.18 million as of August 27, 2025. Its market cap has decreased by -18.09% in one year.
Market Cap
6.18M
Enterprise Value
-5.17M
1-Year Change
-18.09%
Ranking
Category
Stock Price
$3.24
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $490.64M to $6.18M, a decrease of -98.74%. That is a compound annual growth rate of -42.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 6.18M | 32.35% |
| Dec 31, 2024 | 4.67M | -69.80% |
| Dec 29, 2023 | 15.47M | -54.67% |
| Dec 30, 2022 | 34.12M | -72.26% |
| Dec 31, 2021 | 123.00M | -45.94% |
| Dec 31, 2020 | 227.51M | 16.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.76B |
| Johnson & Johnson | 425.05B |
| AbbVie | 368.08B |
| UnitedHealth Group | 272.09B |
| AstraZeneca | 251.25B |
| Novartis AG | 244.09B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 229.03B |